Tobradex and Combivent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tobradex (dexamethasone; tobramycin) and Combivent (albuterol sulfate; ipratropium bromide). Common drug interactions include abdominal discomfort among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Tobradex and Combivent. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Tobradex?

Tobradex has active ingredients of dexamethasone; tobramycin. It is often used in eye infection. eHealthMe is studying from 3,154 Tobradex users. Check the latest studies of Tobradex.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.



On Jul, 12, 2026

23 people who take Tobradex and Combivent together, and have interactions are studied.

Tobradex and Combivent drug interactions.

What are the common drug interactions of Tobradex and Combivent, by gender? *:

female:

  1. Abdominal discomfort
  2. Alopecia (absence of hair from areas of the body)
  3. Anaemia (lack of blood)
  4. Aortic valve sclerosis (narrowing of the aortic valve)
  5. Asthenia (weakness)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Blood glucose increased
  8. Bone disorder
  9. Breast cancer metastatic
  10. Breast cyst

male:

  1. Renal failure (kidney dysfunction)
  2. Chest pain
  3. Osteomyelitis (infection of bone)
  4. Pain
  5. Skin amp subcutaneous tissue abscess (infection of the skin and subcutaneous tissue)
  6. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  7. Weight increased
  8. Abdominal pain
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Atrioventricular block (heart block)

What are the common drug interactions of Tobradex and Combivent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Alopecia (absence of hair from areas of the body)
  3. Anaemia (lack of blood)
  4. Anxiety
  5. Aortic valve sclerosis (narrowing of the aortic valve)
  6. Asthenia (weakness)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Blood glucose increased
  9. Bone disorder
  10. Breast cancer metastatic

50-59:

  1. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  2. Abdominal discomfort
  3. Alopecia (absence of hair from areas of the body)
  4. Anaemia (lack of blood)
  5. Aortic arteriosclerosis (hardening of the aortic arteries)
  6. Aortic valve sclerosis (narrowing of the aortic valve)
  7. Asthenia (weakness)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Back pain

60+:

  1. Chest pain
  2. Renal failure (kidney dysfunction)
  3. Pain
  4. Skin amp subcutaneous tissue abscess (infection of the skin and subcutaneous tissue)
  5. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  6. Weight increased
  7. Abdominal pain
  8. Anxiety
  9. Ascites (accumulation of fluid in the abdominal cavity)
  10. Atrioventricular block (heart block)

What are the existing conditions these people have? *

  1. Pain In Jaw: 5 people, 21.74%
  2. Metastases To Bone (cancer spreads to bone): 5 people, 21.74%
  3. Breast Cancer: 5 people, 21.74%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 17.39%
  5. Pain: 2 people, 8.70%
  6. High Blood Pressure: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Tobradex and Combivent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tobradex and Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tobradex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Combivent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tobradex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combivent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone; tobramycin and albuterol sulfate; ipratropium bromide (the active ingredients of Tobradex and Combivent, respectively), and Tobradex and Combivent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: